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1. INTRODUCTION
Methods  are  required  that  enable  diff e r e n t i a t i o n
between muscle and non-muscle tissues such as liver,
kidney and heart in meat samples. This is because only
muscle tissue is considered meat from the point of
view  of  labelling  (Food  Labelling  (Amendment)
(England)  Regulations  2003)  and  Quantitative
Ingredient Declaration (QUID), and also certain parts
of the carcass are prohibited to be used in raw meat
products  (Meat  Products  (England)  Regulations
2003). Included in the prohibited offal is brain and
spinal cord. The described methodology has therefore
been developed primarily to enforce labelling rules
and also to contribute to the enforcement of BSE
legislation requiring the detection of Central Nervous
System (CNS) tissue. This requires the removal of
central nervous system tissue from carcasses prior to
processing (Government UK, 1989). To permit eff e c t i v e
enforcement there is a need for the development of
robust  CNS  specific  detection  methods  that  are
applicable to a wide range of processed meat products.
Methods for the detection of CNS tissue in meat
include direct tissue examination (Bauer et al., 1996),
histological preparation and microscopic examination
(FSIS/USDA, 1998) and the analysis of cholesterol
content (Lücker et al., 1999; Schmidt et al., 1999).
The latter method has used antibodies directed against
CNS specific proteins to enable the immunogenic
detection of CNS tissue. One of these (Schmidt et al.,
1999) utilises an ELISA method based upon the
detection of Glial Fibrillary Acidic Protein (GFAP), a
protein whose expression is restricted to the CNS
(Kaneko,  Sueoka,  1993).  Our  studies  have  also
utilised detection of GFAP but at the DNA rather than
the protein level. Such an assay may be more suitable
for processed products where DNAdegradation can be
overcome  by  designing  a  PCR  based  assay  that
generates small amplicons and also has the potential to
be utilised on a range of assay formats.
Methylation  of  cytosine  occurring  in  CpG
dinucleotides in the promoter of a gene is one of
several ways of controlling tissue specific regulation
(Condorelli et al., 1994; Condorelli et al., 1997; Teter
et al., 1994). Several tissue specific genes have been
shown to possess unmethylated promoter sequences in
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where little or no expression occurs (Yeivin et al.,
1993). In several cases, methylation of specific CpG
dinucleotides within the promoter has been shown to
correlate with transcriptional repression and hence
control gene expression  (Li et al., 1993; Yoder et al.,
1997).
One technique that can be used to study promoter
methylation is the chemical modification of cytosine
to uracil by bisulphite treatment. In this reaction all
cytosines are converted to uracil but those that are
methylated  (5-methylcytosine)  are  resistant  to
modification  (Wang  e t a l .,  1980).  Following
amplification and sequencing, the converted bases will
appear as thymine compared to cytosine in the native
sequence. The sequence differences resulting from
bisulphite modification of specific bases can also be
used  to  design  PCR  primers  specific  to  the
methylation status of a target template, so called
Methylation  Specific  PCR  (MSP)  (Herman  e t a l .,
1996), allowing discrimination of methylated and non-
methylated sequences. By utilising differences in the
methylation patterns of the GFAP promoter sequence
in bovine and ovine brain and muscle tissue, we have
been able to use MSP to design an assay that enables
the specific detection of brain tissue in both raw and
processed mixed meat samples.
2. DETERMINATION OF METHYLATION
STATUS
Using the high degree of conservation that exists in the
published promoter sequences for human (Besnard
et al., 1991) and rat GFAP (Condorelli et al., 1994), it
was possible to design PCR primers to conserved
regions to amplify ca. 1700 bp of the bovine and sheep
forms of the promoter. Each target was then sequenced
to obtain the native form of the promoter sequence
prior to methylation analysis (GenBank Accession
numbers AF251845 and AF251846).
Genomic  DNA was  isolated  from  samples  of
bovine and ovine brain and spinal cord. Bisulphite
treatment of the DNA was then carried out essentially
as described by Frommer et al. (1992) with some
modifications (Paulin et al., 1998; Woodcock et al.,
1997).  This  procedure  chemically  converts
unmethylated cytosine residues to uracil and leaves
methylated cytosine residues unconverted giving a
permanent record of the methylation status of the gene
in each tissue type. Subsequent PCR amplification
then records the uracil residues as thymine. PCR
primers were designed to amplify only from bisulphite
modified DNAs and not any native (unmodified)
strands. Care was taken to exclude any CpG residues
from the primers where possible. For each tissue type
the target gene was amplified and cloned into a
plasmid vector and replicate plasmids were sequenced
to give a representation of the percentage methylation
in each tissue. Each tissue specific set of sequences
was then compared to that of the native sequence to
determine  any  methylation  differences  (as  the
presence of thymine or cytosine at a CpG target site)
between sequences resulting from muscle or neuronal
derived amplicons. Three cytosine residues contained
between 90 and 100% methylation in muscle derived
DNA and 10% or less in neuronal tissue (based upon
replicate analysis), making them suitable for assay
design.
3. ASSAY DESIGN
PCR primers were designed to discriminate between
methylated (unmodified by bisulphite treatment) and
unmethylated  (modified  by  bisulphite  treatment)
sequences to enable discrimination between skeletal
muscle and neuronal tissue derived DNA. Primers
were designed to encompass a terminal nucleotide at
the 3’ end corresponding to the unmethylated form
(i.e. that derived from neuronal tissue) of cytosine in a
discriminatory CpG site identified within the promoter
sequence.  This  would  be  converted  to  uracil  by
bisulphite modification and hybridise effectively with
the terminal adenosine of the primer. This ensures that
Taq Polymerase cannot efficiently amplify a promoter
sequence containing the methylated form of the gene
(i.e. that derived from muscle tissue) because the
cytosine  residue  is  unchanged,  leading  to  a  3’
mismatch (Figure 1).
F i g u re 2 illustrates  an  example  of  the  tissue
specificity of the neuronal tissue detection assay for
ovine neuronal tissue. An amplicon is visible for DNA
derived from brain tissue but absent for that from
muscle, heart and liver.
4. TRANSFER OF ASSAYS TO OTHER
FORMATS
4.1. Use of a reference gene
In order to detect tissue specific differences in samples
due to methylation status and not as a result of
d i ffering  amounts  of  input  target  material,  it  is
important to have some way of normalising the target
specific  data  before  comparison.  To  this  end  a
reference gene system was developed.  Primers and
probes were designed to amplify part of the target
promoter region that contained no CpG sites in order
to  ensure  that  amplification  was  not  methylation
dependent.  This gave the total signal from all the gene
copies  present  in  the  reaction  (regardless  of
methylation status) and an indication of whether the
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levels of target gene in each reaction were the same. It
also enabled the ratio of the amount of target tissue
specific signal to that of the total promoter signal
(methylated plus unmethylated) to be calculated to
normalise for any differences.
4.2. Real time PCR detection of neuronal tissue
One technique that has been applied for sensitive
detection of methylated alleles using real time PCR
detection is the Methylight assay (Eads et al., 2000).
This  utilises  methylation  specific  amplification
primers as with MSP but also allows the use of
methylation state specific TaqMan probes to add an
extra  level  of  discrimination.  It  also  enables  the
accumulation  of  fluorescence  resulting  from  the
increase  in  amplicon  concentration  during
amplification to be measured, potentially enabling
quantitative PCR measurement. Using this principal,
the  assays  were  further  refined  to  incorporate  a
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Figure 1. Diagram illustrating how it is possible to use the methylation sites identified in target promoters to design a PCR
assay using Methylation Specific PCR (MSP) for the detection of neuronal tissue.
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Figure 2. Demonstration of the tissue specificity of the
ovine neuronal detection assay. Amplification was carried
out on bisulphite treated DNA from brain (lane 1), muscle
(lane 2), heart (lane 3) and liver (lane 4). Lane 5 contains a
minus DNA control. Lane M contains molecular weight
markers.232 Biotechnol. Agron. Soc. Environ. 2004 8 (4), 229–234 Gout S. et al.
fluorescent TaqMan probe containing a methylation
site in the GFAPpromoter to enable the transfer of the
method to the ABI 7700 SDS Prism system. This
enables discrimination of DNA derived from bovine
spinal cord, brain or muscle, by measuring the cycle at
which the accumulated fluorescence signal for each
amplicon crosses a given threshold (Figure 3). 
This  reaction  can  be  run  in  duplex  with  the
reference gene to enable the ratio of the neuronal
specific form to that of the total gene concentration to
be measured as the difference in threshold cycle (DCt).
Using a serie of admixtures of neuronal tissue in
muscle we obtain a linear relationship between DCt
and  target  tissue  concentration  demonstrating  the
quantitative potential of the assay (Figure 4).
4.3. Capillary electrophoresis (CE) based
detection of neuronal tissue
The Agilent CE based detection system relies on the
use  of  conventional  PCR  followed  by  CE  based
separation of amplicons in a polyacrylamide matrix
using a 12 well Labchip. This gives a high level of
product separation and the potential for quantitative
measurement  by  being  able  to  measure  the  net
fluorescent signal obtained for each PCR product and
is a relatively low cost alternative to that of real time
PCR. Reactions were carried out as a duplex utilising
the ratio of the total GFAP amplicon signal obtained
compared to that of the neuronal specific amplicon
signal, to normalise and attempt to quantitate the level
of non-muscle specific amplicon. This method has
been proven to work in a similar fashion for the
quantitative detection of Roundup Ready soya (Burns
et al., 2003) using the ratio of the lectin gene signal
(detecting GM plus non-GM soya) to that of the
Roundup  Ready  soya  specific  amplicon  (GM
specific). It enables a cut off limit to be set, that is
designated as the background signal resulting from
any residual non-methylated GFAP sequence normally
present in muscle tissue which will be linked to the
possible  presence  of  GFA P protein  in  peripheral
nervous system tissue.  Any signal designated as
resulting from neuronal tissue would therefore have to
be above this as compared to a 100% muscle control
run on the chip. 
By using admixtures of neuronal tissue in muscle,
a linear relationship was demonstrated between target
concentration and signal obtained and we were able to
set a threshold for any background non-methylation
present in the muscle sample, giving the basis for
quantitative  measurement  (F i g u re 5).  T h i s
demonstrates the clear potential of the CE system as
an alternative platform for this type of assay.
5. SUMMARY
C u r r e n t l y,  visual  or  histological  examination,
cholesterol  content  or  more  recently  developed
immunoassays can be used to detect neuronal tissue in
meat products. Some of these methods are subjective
and time consuming and may not be applicable to
highly processed samples. We report here a new
technique for the detection of CNS tissue in meat
products  that  exploits  the  robustness  of  DNA,  a
molecule that is relatively resistant to the rigours of
food processing and may give greater applicability to
both raw, processed and cooked meat products.
To enable the use of DNA as the target molecule
we  focused  on  GFA P,  a  gene  that  has  been
characterized as a marker for CNS tissue and has
previously been utilised at the protein level for the
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Figure 4. Linear response between DCt and target tissue
concentration when a series of admixtures of decreasing
amounts of neuronal tissue in a background of muscle are
detected using a TaqMan system on the ABI SDS Prism
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immunogenic  detection  of  CNS  tissue  in  meat
(Schmidt et al., 1999). Tissue specific methylation
patterns for the promoter of this gene have been
reported in several species (Condorelli et al., 1994,
1997; Teter et al., 1994) and this has enabled us to
design a PCR based assay to discriminate between
differentially methylated forms of the same sequence
and hence identify the tissue from which the template
was derived. By utilising the technique of methylation
sensitive PCR (MSP) it was possible to design a PCR
based assay specific to the methylation status of the
GFAP promoter in the target tissue and hence be able
to detect bovine and sheep brain and spinal cord tissue
in a background of non-target muscle tissue.
In conclusion, we have demonstrated the first use
of a PCR based assay for the specific detection of
D N A derived  from  neuronal  tissue  in  muscle
admixtures. This has utilised methylation specific
PCR (MSP), a technique previously only used to
distinguish between tumour and non-tumour tissue in
carcinogenesis. Further work is now underway on the
use of one non-gel based detection platform, the
Agilent CE system, in order to fully validate the
method for the detection of neuronal and other non-
muscle targets in a muscle background.
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